(S)-2-((S)-6,7-Dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4- dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide
CAS: 2055114-67-3
Ref. 3D-FHD11467
| 1g | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued |
Product Information
Name:
(S)-2-((S)-6,7-Dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4- dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide
Synonyms:
- (αS,1S)-3,4-Dihydro-6,7-dimethoxy-N-methyl-α-phenyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-2(1H)-isoquinolineacetamide
- 2(1H)-Isoquinolineacetamide, 3,4-dihydro-6,7-dimethoxy-N-methyl-α-phenyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-, (αS,1S)-
Description:
(S)-2-((S)-6,7-Dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4- dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide is a potent and selective histamine H3 receptor antagonist. It has shown to reduce the incidence of cataplexy in narcolepsy patients and improve wakefulness in healthy subjects. The compound was also found to be effective in the treatment of hepatic impairment. This drug interacts with the liver by inhibiting sodium-dependent glucose transport and decreasing locomotor activity. The compound also showed clinical relevance as an antidiabetic agent for the management of type 2 diabetes mellitus.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
512.6 g/mol
Formula:
C29H31F3N2O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
